Rate My Professor Takakazu Kawase

Fujita Health University identifies a specific HLA mismatch tripling severe GVHD risk in UCBT, analyzing 7,462 cases. Implications for donor selection and survival in Japan's leading cord blood program.

Fujita Health University's landmark study reveals a specific HLA mismatch tripling severe acute GVHD risk in cord blood transplants, revolutionizing donor selection and improving outcomes for blood cancer patients.